Total Payments
$142,262
2024 Payments
$72,173
Companies
25
Transactions
107
Medicare Patients
2,378
Medicare Billing
$158,155
Payment Breakdown by Category
Research$70,425 (49.5%)
Consulting$68,434 (48.1%)
Food & Beverage$1,990 (1.4%)
Travel$1,405 (1.0%)
Education$8.90 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $70,425 | 18 | 49.5% |
| Consulting Fee | $68,434 | 29 | 48.1% |
| Food and Beverage | $1,990 | 55 | 1.4% |
| Travel and Lodging | $1,405 | 4 | 1.0% |
| Education | $8.90 | 1 | 0.0% |
Payments by Type
General
$71,837
89 transactions
Research
$70,425
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CVRx, Inc. | $59,728 | 28 | $0 (2023) |
| Ortho-Clinical Diagnostics, Inc. | $50,325 | 8 | $0 (2024) |
| Artivion, Inc. | $16,200 | 8 | $0 (2024) |
| Novo Nordisk Inc | $14,027 | 12 | $0 (2024) |
| Currax Pharmaceuticals LLC | $400.00 | 1 | $0 (2024) |
| Cardiovascular Systems Inc. | $226.00 | 1 | $0 (2018) |
| Boston Scientific Corporation | $156.35 | 3 | $0 (2024) |
| AtriCure, Inc. | $149.64 | 1 | $0 (2022) |
| Gilead Sciences Inc | $143.38 | 4 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $130.35 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72,173 | 26 | Ortho-Clinical Diagnostics, Inc. ($50,325) |
| 2023 | $12,358 | 7 | Artivion, Inc. ($8,800) |
| 2022 | $13,301 | 6 | CVRx, Inc. ($13,125) |
| 2021 | $7,029 | 7 | CVRx, Inc. ($6,913) |
| 2020 | $8,589 | 6 | CVRx, Inc. ($8,575) |
| 2019 | $9,752 | 7 | CVRx, Inc. ($9,713) |
| 2018 | $11,914 | 8 | CVRx, Inc. ($11,533) |
| 2017 | $7,145 | 40 | CVRx, Inc. ($6,370) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | LATITUDE Communicator Power Supply (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: LATITUDE_CRM | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $11,431.25 | General |
| 12/05/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $563.31 | General |
| 12/05/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $403.13 | General |
| 12/05/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $212.06 | General |
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $189.26 | General |
| 12/04/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $775.00 | General |
| 11/21/2024 | Artivion, Inc. | AMDS-Ascyrus Medical (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: PERSEVERE • Category: Cardiovascular and vascular surgery | ||||||
| 11/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.48 | General |
| 11/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $8.90 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $134.41 | General |
| 09/11/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $4,650.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 09/11/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $675.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 08/08/2024 | Artivion, Inc. | AMDS-Ascyrus Medical (Device) | — | Cash or cash equivalent | $800.00 | Research |
| Study: PERSEVERE • Category: Cardiovascular and vascular surgery | ||||||
| 07/17/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 07/02/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 06/06/2024 | Artivion, Inc. | AMDS-Ascyrus Medical (Device) | — | Cash or cash equivalent | $800.00 | Research |
| Study: PERSEVERE • Category: Cardiovascular and vascular surgery | ||||||
| 05/22/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 05/01/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 04/24/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 04/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $102.77 | General |
| 04/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $55.54 | General |
| 04/03/2024 | Ortho-Clinical Diagnostics, Inc. | VITROS (Device), VITROS, VITROS | — | Cash or cash equivalent | $7,500.00 | Research |
| Study: VITROS Immunodiagnostic Products hs Troponin I • Category: DIAGNOSTICS | ||||||
| 03/27/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | — | Cash or cash equivalent | $400.00 | Research |
| Study: NB (Contrave) Cardiovascular Outcomes Trial • Category: Obesity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| VITROS Immunodiagnostic Products hs Troponin I | Ortho-Clinical Diagnostics, Inc. | $50,325 | 8 |
| PERSEVERE | Artivion, Inc. | $16,200 | 8 |
| NB (Contrave) Cardiovascular Outcomes Trial | Currax Pharmaceuticals LLC | $400.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 280 | 374 | $88,277 | $28,189 |
| 2022 | 11 | 336 | 401 | $92,726 | $29,615 |
| 2021 | 20 | 980 | 1,141 | $220,321 | $56,215 |
| 2020 | 18 | 782 | 871 | $177,931 | $44,136 |
Total Patients
2,378
Total Services
2,787
Medicare Billing
$158,155
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 83 | $24,153 | $7,338 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 102 | $16,086 | $6,067 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 67 | $14,897 | $5,351 | 35.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 43 | $8,299 | $2,526 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,398 | $1,688 | 49.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,936 | $1,659 | 27.9% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 15 | 15 | $8,280 | $1,379 | 16.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 20 | $4,060 | $1,228 | 30.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $3,168 | $952.64 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 77 | $16,133 | $6,060 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 92 | $13,252 | $5,765 | 43.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 58 | $13,536 | $4,398 | 32.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 34 | $10,433 | $3,180 | 30.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $8,646 | $2,755 | 31.9% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2022 | 20 | 20 | $11,040 | $1,877 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,342 | $1,836 | 42.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 27 | $4,274 | $1,435 | 33.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 26 | 26 | $7,578 | $1,193 | 15.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 20 | $3,210 | $1,065 | 33.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 11 | 11 | $283.50 | $51.28 | 18.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 208 | 213 | $60,686 | $11,251 | 18.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 99 | $21,285 | $7,592 | 35.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 86 | $16,420 | $7,068 | 43.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 88 | $10,750 | $4,940 | 46.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 75 | $11,250 | $4,093 | 36.4% |
About Dr. Michael Hall, M.D
Dr. Michael Hall, M.D is a Emergency Medicine healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235340225.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hall, M.D has received a total of $142,262 in payments from pharmaceutical and medical device companies, with $72,173 received in 2024. These payments were reported across 107 transactions from 25 companies. The most common payment nature is "" ($70,425).
As a Medicare-enrolled provider, Hall has provided services to 2,378 Medicare beneficiaries, totaling 2,787 services with total Medicare billing of $158,155. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Jackson, MS
- Active Since 05/24/2007
- Last Updated 10/31/2016
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1235340225
Products in Payments
- Barostim Neo System (Device) $59,728
- VITROS (Device) $50,325
- AMDS-Ascyrus Medical (Device) $16,200
- CONTRAVE (Drug) $400.00
- Peripheral Orbital Atherectomy System (Device) $226.00
- SYNERGY ABLATION SYSTEM (Device) $149.64
- ENTRESTO (Drug) $130.35
- Connectivity and Remote care (Device) $101.04
- BRILINTA (Drug) $96.41
- EXALT (Device) $95.83
- ORENITRAM (Drug) $79.04
- ELIQUIS (Drug) $76.69
- XARELTO (Drug) $60.76
- Lexiscan (Drug) $41.26
- LifeVest (Device) $26.91
- HAWKONE (Device) $26.78
- ECM Patch (Device) $26.58
- LATITUDE Communicator Power Supply (Device) $21.28
- MitraClip System (Device) $20.96
- SAMSCA (Drug) $19.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Jackson
Dr. Richard Summers, M.d, M.D
Emergency Medicine — Payments: $103,110
Emergency Medicine $103,110
Bob Hutchins
Emergency Medicine — Payments: $65,282
Emergency Medicine $65,282
Stephen Bergquist, Md, MD
Emergency Medicine — Payments: $28,123
Emergency Medicine $28,123
Adewale Odukoya, Md, MD
Emergency Medicine — Payments: $21,171
Emergency Medicine $21,171
Dr. Utsav Nandi, M.d, M.D
Emergency Medicine — Payments: $17,609
Emergency Medicine $17,609
Dr. Damon Darsey, M.d, M.D
Emergency Medicine — Payments: $17,425
Emergency Medicine $17,425